A predictive model for pain response following radiotherapy for treatment of spinal metastases.
Adult
Aged
Aged, 80 and over
Disease Management
Disease Susceptibility
Female
Humans
Image Processing, Computer-Assisted
Male
Middle Aged
Pain
/ diagnosis
Prognosis
ROC Curve
Radiotherapy
/ methods
Research Design
Retrospective Studies
Spinal Neoplasms
/ complications
Tomography, X-Ray Computed
Treatment Outcome
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
18 06 2021
18 06 2021
Historique:
received:
23
12
2020
accepted:
03
06
2021
entrez:
19
6
2021
pubmed:
20
6
2021
medline:
6
11
2021
Statut:
epublish
Résumé
To establish a predictive model for pain response following radiotherapy using a combination of radiomic and clinical features of spinal metastasis. This retrospective study enrolled patients with painful spine metastases who received palliative radiation therapy from 2018 to 2019. Pain response was defined using the International Consensus Criteria. The clinical and radiomic features were extracted from medical records and pre-treatment CT images. Feature selection was performed and a random forests ensemble learning method was used to build a predictive model. Area under the curve (AUC) was used as a predictive performance metric. 69 patients were enrolled with 48 patients showing a response. Random forest models built on the radiomic, clinical, and 'combined' features achieved an AUC of 0.824, 0.702, 0.848, respectively. The sensitivity and specificity of the combined features model were 85.4% and 76.2%, at the best diagnostic decision point. We built a pain response model in patients with spinal metastases using a combination of clinical and radiomic features. To the best of our knowledge, we are the first to examine pain response using pre-treatment CT radiomic features. Our model showed the potential to predict patients who respond to radiation therapy.
Identifiants
pubmed: 34145367
doi: 10.1038/s41598-021-92363-0
pii: 10.1038/s41598-021-92363-0
pmc: PMC8213735
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
12908Références
Eur J Nucl Med Mol Imaging. 2019 Jul;46(7):1468-1477
pubmed: 30915523
Radiology. 2010 Nov;257(2):523-31
pubmed: 20829534
AJR Am J Roentgenol. 1977 Dec;129(6):1095-6
pubmed: 74204
Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):859-866
pubmed: 29063851
AJNR Am J Neuroradiol. 2002 Jun-Jul;23(6):906-12
pubmed: 12063214
Magn Reson Imaging. 2019 Dec;64:4-12
pubmed: 30826448
Support Care Cancer. 2019 Apr;27(4):1335-1343
pubmed: 30105665
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1730-7
pubmed: 21489705
Nat Commun. 2014 Jun 03;5:4006
pubmed: 24892406
Adv Radiat Oncol. 2019 Apr 10;4(3):513-519
pubmed: 31360808
Eur Radiol. 2019 Sep;29(9):4742-4750
pubmed: 30778717
Transl Oncol. 2018 Feb;11(1):31-36
pubmed: 29156383
Acta Radiol. 2011 Jun 1;52(5):557-61
pubmed: 21498309
Sci Rep. 2017 Apr 18;7:46349
pubmed: 28418006
Clin Transl Oncol. 2017 Nov;19(11):1382-1387
pubmed: 28623513
Br J Radiol. 2019 Sep;92(1101):20190286
pubmed: 31219712
Eur J Radiol. 2020 Jul;128:109020
pubmed: 32371181
J Clin Oncol. 2018 Mar 20;36(9):891-899
pubmed: 29412781
J Radiat Res. 2019 Jul 1;60(4):538-545
pubmed: 31111948
Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6243s-6249s
pubmed: 17062708
Thorax. 2007 Jul;62(7):565-8
pubmed: 17327260
J Clin Oncol. 2009 Feb 1;27(4):585-90
pubmed: 19103733
Cancer Imaging. 2019 Jun 7;19(1):34
pubmed: 31174617